NOX 2.94% 6.6¢ noxopharm limited

in terms of drug getting Fda approval, it needs to do trials....

  1. 1,016 Posts.
    lightbulb Created with Sketch. 37
    in terms of drug getting Fda approval, it needs to do trials. This study though gives GenisisCare a case to use Veyonda and lu psma on compasionate grounds. I would expect some sort of revenue pickup.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.002(2.94%)
Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.31K 198.1K

Buyers (Bids)

No. Vol. Price($)
1 1137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 15.50pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.